0.9% SODIUM CHLORIDE IRRIGATION
- Manufacturer
- AMCO INTERNATIONAL CORP
- Effective date
- 2024-12-16
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 21:19:35
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INSTRUCTIONS FOR USE SECTION
Directions for Use of Flexible Plastic Irrigation Containers
If desired, warm in overwrap to near body temperature in a water bath or oven heated to not more than 45°C. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
DIRECTIONS FOR USE
Tear overwrap down side at slit and remove solution container. Visually inspect the container. If the outlet port protector is damaged, detached, or not present, discard container as solution path sterility may be impaired. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing bag firmly. If leaks are found, discard solution as sterility may be impaired. Use Aseptic Technique. 1.Suspend container using hanger hole. 2.Remove plastic protector from outlet port at bottom of container 3.Attach irrigation set. Refer to complete directions accompanying set. Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C): brief exposure up to 40°C does not adversely affect the product
HEALTH CARE PROVIDER LETTER SECTION
Dear Healthcare Professional,
To prevent a drug shortage of large volume parenteral fluid drug products, we plan
to coordinate with the U.S. Food and Drug Administration (FDA) to temporarily import 0.9% Sodium Chloride IRRIGATION ( 3,000 mL) from specific DRE
manufacturing facilities. FDA has not approved these products manufactured by this facility. We are also working to label and produce this drug domestically in the United States.
You may be provided with additional letters for other imported products you receive. Please read each letter in its entirety because each letter may contain different product specific information.
All labels are in English with NDC listed on label.
It is important to note the following:
After opening the carton or box, the bags should be inspected visually to confirm there is no visible particulate matter or bag defects, such as leaks. Container integrity is imperative to ensure sterility of products. Parenteral drug products should be inspected visually for particulate matter and bag defects prior to administration, whenever solution or container permits.
USE A NEW BAG IF PARTICULATES ARE VISIBLE OR IF THE IV BAG CONTAINS A LEAK.
Reporting Adverse Events or Product Quality Issues
To report adverse events associated with these imported products, please call AMCO at+1 833 3 MY AMCO.
. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax
• Complete and submit the report Online:
www.fda.gov/medwatch/report.htm
• Regular mail or Fax: Download form
www.fda.gov/MedWatch/getforms.htm or call
1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178 (1-800-332-0178).
To report product quality issues associated with these imported products, please contact AMCO at +1 833 3 MY AMCO.
If you have any questions about the information contained in this letter or the use of the imported products, please Contact +1 833 3 MY AMCO.
To place an order, please contact AMCO at +1 833 3 MY AMCO.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
3000 mL NDC NOT FOR INJECTION 0.9% SODIUM CHLORIDE Irrigation USP Each 100 mL contains 900 mg Sodium Chloride USP No antimicrobial agent has been added pH 5.5 (4.5 to 7.0) mEq/L Sodium 154 Chloride 154 Osmolarity 308 mOsmol/L (calc) Sterile Nonpyrogenic Single dose container Do not use unless solution is clear Discard unused portion Cautions Squeeze and inspect inner bag which maintains product sterility Discard if leaks are found Rx Only Store unit in moisture barrier overwrap at room temperature (25°C) until ready to use Avoid excessive heat See insert 0.9% Sodium Chloride NaCl Irrigation USP
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84866-6670-1 | 0.9% SODIUM CHLORIDE IRRIGATION | 3000 mL in 1 BAG | IRRIGANT | 3000 | 1 | |
| 84866-6670-4 | 0.9% SODIUM CHLORIDE IRRIGATION | 10 in 1 CARTON | IRRIGANT | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 84866-6670 | 0.9% SODIUM CHLORIDE IRRIGATION (BLUE PHARMA, TOTALCARE, 0.9% SODIUM CHLORIDE IRRIGATION) IRRIGANT [AMCO INTERNATIONAL CORP] | 1 | 2 package rows | 20241218_29682ecd-0b01-5e83-e063-6294a90a0e12.zip |
Products#
Every source-derived product name is available through these pages.
- 0.9% SODIUM CHLORIDE IRRIGATION
- BLUE PHARMA, TOTALCARE, 0.9% SODIUM CHLORIDE IRRIGATION
- SODIUM CHLORIDE
- SODIUM CATION
- CHLORIDE ION
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84866-6670 | 84866-6670-1, 84866-6670-4 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 29682ecd-0b02-5e83-e063-6294a90a0e12 | 29682ecd-0b01-5e83-e063-6294a90a0e12 | 2024-12-16 | 29682ecd-0b02-5e83-e063-6294a90a0e12 29682ecd-0b01-5e83-e063-6294a90a0e12 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

